LGC Acquires Lucigen
Summary
LGC has acquired Lucigen, a company that develops and supplies molecular biology enzymes, reagents, and kits. Lucigen’s portfolio includes next-generation sequencing kits, competent cells, cloning systems, and related life science products. The deal expands LGC’s exposure to the NGS and gene editing markets and strengthens its offerings for molecular diagnostics, agbio, and biopharma customers. The acquisition also brings complementary manufacturing and product development capabilities into LGC’s genomics division.
Classifications
industries
Pharmaceuticals and Chemical
applications
Data Management
AskAI Classifications
Labels
Bioinformatics Software
Laboratory Information Management Systems
Genomics Software
Linked Companies
Biosearch Technologies
$100M to $250M